Capstone Investment Advisors’s Veracyte VCYT Stock Holding History

Capstone Investment Advisors’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$409K	Buy	+12,708	New	+$470K	﹤0.01%	1229
2025 Q4	–	Sell	-9,423	Closed	-$323K	–	2075
2025 Q3	$323K	Sell	9,423 -1,385	-13%	-$39.7K	﹤0.01%	1619
2025 Q2	$292K	Sell	10,808 -14,792	-58%	-$428K	﹤0.01%	1388
2025 Q1	$759K	Buy	+25,600	New	+$976K	﹤0.01%	963
2024 Q2	–	Sell	-13,365	Closed	-$296K	–	2498
2024 Q1	$296K	Buy	+13,365	New	+$326K	﹤0.01%	1843

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Capstone Investment Advisors's VCYT Position: Q1 2026 in Review

Capstone Investment Advisors opened a new position in Veracyte (VCYT) in Q1 2026: 12,708 shares worth $409K. The stake represents ﹤0.01% of the portfolio and ranks #1229 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in VCYT as recently as Q3 2025.

Capstone Investment Advisors first reported a position in VCYT in Q1 2024 and has held it in 5 quarters since. The position peaked at $759K in Q1 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

Capstone Investment Advisors held 12,708 shares of Veracyte worth $409K as of Q1 2026.
Veracyte was a new Capstone Investment Advisors position in Q1 2026.
Veracyte made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1229 holding.
Capstone Investment Advisors first reported a position in Veracyte in Q1 2024 and has held it in 5 quarters since.
Capstone Investment Advisors's Veracyte position peaked at $759K in Q1 2025.
334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.